𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Parkinson's disease, primates, and gene therapy: Vive la différence?

✍ Scribed by Travis B. Lewis; David G. Standaert

Book ID
102506422
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
48 KB
Volume
26
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene therapy for Parkinson's disease
Gene therapy for Parkinson's disease
✍ Tomas Bjorklund; Jeffrey H. Kordower 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract The once fantastic theoretical concept that patients with Parkinson's disease (PD) would receive gene therapy in an attempt to alleviate their symptoms and potentially modify the course of their disease has become a reality. On the basis of positive preclinical data, four different gene

Intravenous glial-derived neurotrophic f
Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter
✍ Chun-Fang Xia; Ruben J. Boado; Yun Zhang; Chun Chu; William M. Pardridge 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

## Abstract ## Background Rats with experimental Parkinson's disease (PD) are treated with intravenous glial‐derived neurotrophic factor (GDNF) plasmid DNA, non‐viral gene therapy using Trojan horse liposomes (THLs) targeted with a monoclonal antibody (MAb) to the rat transferrin receptor (TfR). E